Clinical Trial

AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication

Study acronym: AdLip
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 3, 2024 (before its estimated February 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
Investigators hypothesize that the use of a human coach-supported digital/AI personal health assistant (app) will improve adherence to cholesterol-lowering medications (statins with or without ezetimibe) among patients with hyperlipidaemia and suboptimal LDL-C control, when compared to standard care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-23.
Trial Details
NCT Number NCT06614049
Lead Sponsor National University of Singapore
Collaborators: National University Polyclinics, Singapore, Nanyang Technological University, National Healthcare Group Polyclinics, Consortium for Clinical Research and Innovation, Singapore (CRIS), National University Heart Centre, Singapore
Conditions Hyperlipidemia, Medication Nonadherence
Enrollment 450 participants
Start Date 2024-06-10
Primary Completion 2026-02-14 (estimated)
Study Completion 2026-02-14 (estimated)
Updated on ClinicalTrials.gov 2024-10-03